Ambu A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMBBY research report →
About the company
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope.
- CEO
- Britt Meelby Jensen
- IPO
- 2021
- Employees
- 5,292
- HQ
- Ballerup, DK
Price Chart
- Market Cap
- $2.58B
- P/E
- 37.25
- P/S
- 2.90
- P/B
- 2.91
- EV/EBITDA
- 16.96
- Div Yield
- 0.62%
- Gross Margin
- 55.82%
- Op Margin
- 10.71%
- Net Margin
- 7.81%
- ROE
- 7.92%
- ROIC
- 7.56%
- Revenue
- $5.69B · 5.47%
- Net Income
- $573.61M · 144.09%
- EPS
- $2.15 · 144.32%
- Op Income
- $738.45M
- FCF YoY
- 21.15%
- 52W High
- $16.78
- 52W Low
- $8.54
- 50D MA
- $9.98
- 200D MA
- $12.54
- Beta
- 1.36
- Avg Volume
- 182
Get TickerSpark's AI analysis on AMBBY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AMBBY coverage
Recent articles, reports, and earnings notes.
No research on AMBBY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AMBBY report →Similar companies
Peers in the same neighborhood.